Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 3/2013

01.06.2013 | Research Article

Drug-related problems in prescribed medicines in Germany at the time of dispensing

verfasst von: Andrea Nicolas, Christiane Eickhoff, Nina Griese, Martin Schulz

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Background Drug-related problems (DRPs) can have an important impact on the effectiveness and safety of pharmacotherapy. In Germany, the frequency of DRPs in prescribed medicines in ambulatory care is not yet known. Objective To quantify DRPs in prescribed medicines identified by community pharmacists (CPs) at the time the medicine is dispensed. Setting German CPs in four different regions. Method We invited CPs to document one hundred consecutive patients presenting prescriptions using a standardized documentation form. For each patient, person- and medication-related as well as identified DRP-related data were documented. Data were transcribed electronically, coded if necessary, checked for validity, and analyzed. Main outcome measure Nature and frequency of DRPs. Results In total, 143 CPs documented 14,231 patients with 24,422 prescribed drugs and identified DRPs in 2,556 patients (18.0 %). Analyses resulted in 0.23 DRPs per patient and 0.13 DRPs per prescribed medicine. Four DRPs were responsible for almost 70 % of all DRPs: Potential drug–drug interaction (22.9 %), dose not known to patient (21.7 %), patient insecure due to generic substitution (13.5 %), and insufficient patient knowledge of correct drug use (10.9 %). If a patient’s drug file was kept in the pharmacy, specific types of DRPs were detected more frequently e.g., drug–drug interactions (p < 0.001). Interventions primarily comprised counselling, monitoring, and changing drug or instructions for use. The prescribing physician was contacted in 28 % of DRPs resulting in a change of these prescriptions in 50 % of the cases. Overall and according to the pharmacists, more than 90 % of the DRPs detected were partially (10.4 %) or completely (85.4 %) solved. Conclusion We quantified DRPs in prescribed medicines in daily ambulatory care practice in Germany. When filling a prescription, in nearly 20 % of the patients relevant DRPs were revealed. According to the pharmacists, the majority could be partially or completely solved during the encounter at the pharmacy. Keeping a patient’s drug file including patient specific data may facilitate the detection of DRPs and shall, therefore, be offered to patients more often.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24:46–54.PubMedCrossRef Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24:46–54.PubMedCrossRef
3.
Zurück zum Zitat Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5.PubMedCrossRef Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5.PubMedCrossRef
4.
Zurück zum Zitat Pouyanne P, Haramburu F, Imbs JL, Begaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French pharmacovigilance centres. BMJ. 2000;320:1036.PubMedCrossRef Pouyanne P, Haramburu F, Imbs JL, Begaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French pharmacovigilance centres. BMJ. 2000;320:1036.PubMedCrossRef
5.
Zurück zum Zitat Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems. J Clin Pharm Ther. 2009;34:319–27.PubMedCrossRef Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems. J Clin Pharm Ther. 2009;34:319–27.PubMedCrossRef
6.
Zurück zum Zitat Winterstein AG, Sauer BC, Hepler CD, Poole C. Preventable drug-related hospital admissions. Ann Pharmacother. 2002;36:1238–48.PubMedCrossRef Winterstein AG, Sauer BC, Hepler CD, Poole C. Preventable drug-related hospital admissions. Ann Pharmacother. 2002;36:1238–48.PubMedCrossRef
7.
Zurück zum Zitat Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995;155:1949–56.PubMedCrossRef Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995;155:1949–56.PubMedCrossRef
8.
Zurück zum Zitat Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001;41:192–9. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001;41:192–9.
9.
Zurück zum Zitat Eichenberger PM, Lampert ML, Kahmann IV, van Mil JW, Hersberger KE. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci. 2010;32:362–72.PubMedCrossRef Eichenberger PM, Lampert ML, Kahmann IV, van Mil JW, Hersberger KE. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci. 2010;32:362–72.PubMedCrossRef
10.
Zurück zum Zitat Hämmerlein A, Griese N, Schulz M. Survey of drug-related problems identified by community pharmacies. Ann Pharmacother. 2007;41:1825–32.PubMedCrossRef Hämmerlein A, Griese N, Schulz M. Survey of drug-related problems identified by community pharmacies. Ann Pharmacother. 2007;41:1825–32.PubMedCrossRef
11.
Zurück zum Zitat Lewinski D, Wind S, Belgardt C, Plate V, Behles C, Schweim HG. Prevalence and safety-relevance of drug-related problems in German community pharmacies. Pharmacoepidemiol Drug Saf. 2010;19:141–9.PubMedCrossRef Lewinski D, Wind S, Belgardt C, Plate V, Behles C, Schweim HG. Prevalence and safety-relevance of drug-related problems in German community pharmacies. Pharmacoepidemiol Drug Saf. 2010;19:141–9.PubMedCrossRef
12.
Zurück zum Zitat Westerlund LT, Marklund BR, Handl WH, Thunberg ME, Allebeck P. Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother. 2001;35:1343–9.PubMedCrossRef Westerlund LT, Marklund BR, Handl WH, Thunberg ME, Allebeck P. Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother. 2001;35:1343–9.PubMedCrossRef
13.
Zurück zum Zitat Westerlund T, Almarsdottir AB, Melander A. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Pract. 1999;7:40–50.CrossRef Westerlund T, Almarsdottir AB, Melander A. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Pract. 1999;7:40–50.CrossRef
14.
Zurück zum Zitat Eickhoff C, Schulz M. Pharmaceutical care in community pharmacies: practice and research in Germany. Ann Pharmacother. 2006;40:729–35.PubMedCrossRef Eickhoff C, Schulz M. Pharmaceutical care in community pharmacies: practice and research in Germany. Ann Pharmacother. 2006;40:729–35.PubMedCrossRef
15.
Zurück zum Zitat Eickhoff C, Hämmerlein A, Griese N, Schulz M. Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany. Pharmacoepidemiol Drug Saf. 2012;21:254–60.PubMedCrossRef Eickhoff C, Hämmerlein A, Griese N, Schulz M. Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany. Pharmacoepidemiol Drug Saf. 2012;21:254–60.PubMedCrossRef
16.
Zurück zum Zitat ABDA—Bundesvereinigung Deutscher Apothekerverbände. Leitfaden “Beratung in der Apotheke”; 2010. ABDA—Bundesvereinigung Deutscher Apothekerverbände. Leitfaden “Beratung in der Apotheke”; 2010.
17.
Zurück zum Zitat WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo; 2003. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo; 2003.
18.
Zurück zum Zitat ABDATA Pharma-Daten-Service. ABDA-Datenbank [computer program]. Werbe- und Vertriebsgesellschaft Deutscher Apotheker mbH. Germany: Eschborn; 2010. ABDATA Pharma-Daten-Service. ABDA-Datenbank [computer program]. Werbe- und Vertriebsgesellschaft Deutscher Apotheker mbH. Germany: Eschborn; 2010.
19.
Zurück zum Zitat Ax F, Branstad J-O, Westerlund T. Pharmacy counselling models: a means to improve drug use. J Clin Pharm Ther. 2010;35:439–51.PubMed Ax F, Branstad J-O, Westerlund T. Pharmacy counselling models: a means to improve drug use. J Clin Pharm Ther. 2010;35:439–51.PubMed
20.
Zurück zum Zitat Benrimoj SI, Langford JH, Berry G, Collins D, Lauchlan R, Stewart K, et al. Clinical intervention rates in community pharmacy: a randomised trial of the effect of education and a professional allowance. Int J Pharm Pract. 2003;11:71–80.CrossRef Benrimoj SI, Langford JH, Berry G, Collins D, Lauchlan R, Stewart K, et al. Clinical intervention rates in community pharmacy: a randomised trial of the effect of education and a professional allowance. Int J Pharm Pract. 2003;11:71–80.CrossRef
21.
Zurück zum Zitat Poston J, Kennedy R, Waruszynski B. Initial results from the community pharmacist intervention study. Can Pharm J. 1995;127:18–24. Poston J, Kennedy R, Waruszynski B. Initial results from the community pharmacist intervention study. Can Pharm J. 1995;127:18–24.
22.
Zurück zum Zitat Rupp MT, DeYoung M, Schondelmeyer SW. Prescribing problems and pharmacist interventions in community practice. Med Care. 1992;30:926–40.PubMedCrossRef Rupp MT, DeYoung M, Schondelmeyer SW. Prescribing problems and pharmacist interventions in community practice. Med Care. 1992;30:926–40.PubMedCrossRef
23.
Zurück zum Zitat van Mil JW, Dudok van Heel MC, Boersma M, Tromp TF. Interventions and documentation for drug-related problems in Dutch community pharmacies. Am J Health Syst Pharm. 2001;58:1428–31.PubMed van Mil JW, Dudok van Heel MC, Boersma M, Tromp TF. Interventions and documentation for drug-related problems in Dutch community pharmacies. Am J Health Syst Pharm. 2001;58:1428–31.PubMed
24.
Zurück zum Zitat Andersson AC, Brodin H, Nilsson JLG. Pharmacist interventions in relation to patient drug-related problems. J Soc Adm Pharm. 2003;20:82–91. Andersson AC, Brodin H, Nilsson JLG. Pharmacist interventions in relation to patient drug-related problems. J Soc Adm Pharm. 2003;20:82–91.
25.
Zurück zum Zitat Buurma H, De Smet PA, van den Hoff OP, Egberts AC. Nature, frequency and determinants of prescription modifications in Dutch community pharmacies. Br J Clin Pharmacol. 2001;52:85–91.PubMedCrossRef Buurma H, De Smet PA, van den Hoff OP, Egberts AC. Nature, frequency and determinants of prescription modifications in Dutch community pharmacies. Br J Clin Pharmacol. 2001;52:85–91.PubMedCrossRef
26.
Zurück zum Zitat Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47:695–700.PubMedCrossRef Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47:695–700.PubMedCrossRef
27.
Zurück zum Zitat Leemans L, Veroeveren L, Bulens J, Hendrickx C, Keyenberg W, Niesten F, et al. Frequency and trends of interventions of prescriptions in Flemish community pharmacies. Pharm World Sci. 2003;25:65–9.PubMedCrossRef Leemans L, Veroeveren L, Bulens J, Hendrickx C, Keyenberg W, Niesten F, et al. Frequency and trends of interventions of prescriptions in Flemish community pharmacies. Pharm World Sci. 2003;25:65–9.PubMedCrossRef
28.
Zurück zum Zitat Westein MP, Herings RM, Leufkens HG. Determinants of pharmacists’ interventions linked to prescription processing. Pharm World Sci. 2001;23:98–101.PubMedCrossRef Westein MP, Herings RM, Leufkens HG. Determinants of pharmacists’ interventions linked to prescription processing. Pharm World Sci. 2001;23:98–101.PubMedCrossRef
Metadaten
Titel
Drug-related problems in prescribed medicines in Germany at the time of dispensing
verfasst von
Andrea Nicolas
Christiane Eickhoff
Nina Griese
Martin Schulz
Publikationsdatum
01.06.2013
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 3/2013
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9769-9

Weitere Artikel der Ausgabe 3/2013

International Journal of Clinical Pharmacy 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.